Clinical Trials
2 trialsNCT05470283 2026-04-16
Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT01867268 2015-04-21
Effect of Acetazolamide & Position in CSF Leakage and Collection and Wound Dehiscence
Tehran University of Medical Sciences
Phase 2 Unknown